Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.

Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.

AIMS: To confirm and extend to primary care settings prior genome-wide association results that distinguish smokers who successfully quit from individuals who were not able to quit smoking in clinical trials. MATERIALS and METHODS: Affymetrix 6.0 Arrays were used to study DNA from successful quitter...

Bibliográfalaš dieđut
Váldodahkkit:	Uhl, G, Drgon, T, Johnson, C, Walther, D, David, S, Aveyard, P, Murphy, M, Johnstone, E, Munafò, MR
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2010

Geahča maid

Erratum: Genome-wide association for smoking cessation success: Participants in the Patch in Practice trial of nicotine replacement (Pharmacogenomics (2010) 11:3 (357-367))
Dahkki: Uhl, G, et al.
Almmustuhtton: (2010)

Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.
Dahkki: David, S, et al.
Almmustuhtton: (2008)

CHRNA3 rs1051730 genotype and short-term smoking cessation.
Dahkki: Munafò, MR, et al.
Almmustuhtton: (2011)

Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.
Dahkki: David, S, et al.
Almmustuhtton: (2011)

Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial.
Dahkki: Munafò, MR, et al.
Almmustuhtton: (2009)

Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial
Dahkki: Munafo, M, et al.
Almmustuhtton: (2009)

Nicotine replacement therapy for smoking cessation.
Dahkki: Silagy, C, et al.
Almmustuhtton: (2001)

Nicotine replacement therapy for smoking cessation.
Dahkki: Silagy, C, et al.
Almmustuhtton: (2001)

Nicotine replacement therapy for smoking cessation
Dahkki: Silagy, C, et al.
Almmustuhtton: (2001)

Nicotine replacement therapy for smoking cessation.
Dahkki: Silagy, C, et al.
Almmustuhtton: (2000)

Nicotine replacement therapy for smoking cessation.
Dahkki: Silagy, C, et al.
Almmustuhtton: (2000)

Nicotine replacement therapy for smoking cessation.
Dahkki: Silagy, C, et al.
Almmustuhtton: (2004)

Nicotine replacement therapy for smoking cessation.
Dahkki: Silagy, C, et al.
Almmustuhtton: (2002)

Nicotine replacement therapy for smoking cessation.
Dahkki: Silagy, C, et al.
Almmustuhtton: (2004)

Nicotine replacement therapy for smoking cessation.
Dahkki: Silagy, C, et al.
Almmustuhtton: (2002)

Nicotine replacement therapy for smoking cessation.
Dahkki: Stead, L, et al.
Almmustuhtton: (2012)

Nicotine replacement therapy for smoking cessation.
Dahkki: Stead, L, et al.
Almmustuhtton: (2008)

Nicotine replacement therapy for smoking cessation.
Dahkki: Silagy, C, et al.
Almmustuhtton: (2000)

Nicotine replacement therapy for smoking cessation.
Dahkki: Silagy, C, et al.
Almmustuhtton: (2000)

Pharmacogenomics of nicotine dependence and impact on smoking cessation
Dahkki: Johnstone, E, et al.
Almmustuhtton: (2007)

Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation.
Dahkki: Spruell, T, et al.
Almmustuhtton: (2012)

Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial.
Dahkki: Johnstone, E, et al.
Almmustuhtton: (2007)

Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial.
Dahkki: Aveyard, P, et al.
Almmustuhtton: (2008)

The effectiveness of nicotine replacement therapies in smoking cessation.
Dahkki: Silagy, C, et al.
Almmustuhtton: (1994)

Nicotine patch preloading for smoking cessation (the preloading trial): study protocol for a randomized controlled trial.
Dahkki: Lindson-Hawley, N, et al.
Almmustuhtton: (2014)

Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch.
Dahkki: David, S, et al.
Almmustuhtton: (2008)

Smoking cessation 2: Nicotine replacement therapy - new tricks with old drugs
Dahkki: Aveyard, P, et al.
Almmustuhtton: (2009)

Smoking cessation 3: Nicotinic partial agonists in smoking cessation - Varenicline and cytisine
Dahkki: Aveyard, P, et al.
Almmustuhtton: (2009)

Nicotine replacement therapy versus control for smoking cessation
Dahkki: Hartmann-Boyce, J, et al.
Almmustuhtton: (2018)

Lack of association of OPRM1 genotype and smoking cessation.
Dahkki: Munafò, MR, et al.
Almmustuhtton: (2013)

Factors associated with smoking cessation in early and late pregnancy in the smoking, nicotine, and pregnancy trial: a trial of nicotine replacement therapy.
Dahkki: Vaz, L, et al.
Almmustuhtton: (2014)

Nicotine-replacement therapy: a proven treatment for smoking cessation
Dahkki: Robson, Noor Zurani
Almmustuhtton: (2010)

Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation.
Dahkki: Silagy, C, et al.
Almmustuhtton: (1994)

Is giving up smoking on the nicotine patch related to genotype?
Dahkki: Yudkin, P, et al.
Almmustuhtton: (2001)

Association of COMT Val108/158Met genotype with smoking cessation.
Dahkki: Munafò, MR, et al.
Almmustuhtton: (2008)

Nicotine vaccines for smoking cessation.
Dahkki: Hartmann-Boyce, J, et al.
Almmustuhtton: (2012)

Smoking cessation, weight gain, and DRD4 -521 genotype
Dahkki: Munafò, MR, et al.
Almmustuhtton: (2006)

Nicotine preloading for smoking cessation: the Preloading RCT
Dahkki: Aveyard, P, et al.
Almmustuhtton: (2018)

Interventions for smoking cessation in hospitalised patients
Dahkki: Rigotti, NA, et al.
Almmustuhtton: (2002)

Association of the mu-opioid receptor gene with smoking cessation.
Dahkki: Munafò, MR, et al.
Almmustuhtton: (2007)